Benzinga’s Top Pre-Market NASDAQ Gainers (ONXX, AONE, GENZ, MLNX)

ONYX Pharmaceuticals Inc ONXX rose 16.42% to $25.03 in the pre-market session. ONXX is planning to seek FDA approval for its new multiple myeloma drug. A123 Systems Inc AONE added 4.46% to $9.84 in pre-market trading. AONE has planned to open a research and development (R&D) facility in Westborough, Massachusetts. Genzyme Corporation GENZ moved up 3.68% to $64.82 in pre-market trading. Sanofi-Aventis SNY has approached GENZ for a takeover in an informal way as the company seeks to enhance its biotechnology offerings. Mellanox Technologies Ltd MLNX gained 3.19% to $17.14 in the pre-market session. MLNX had issued a weak outlook for its Q3 revenues. Read more from Benzinga's Company news.